STAT

STAT+: Pharmalittle: We’re reading about White House eyeing PBMs, Pfizer CEO’s frustrations, and more

In today's Pharmalittle roundup, we're reading about the White House eyeing PBMs, the Pfizer CEO's frustrations, and more.
Source: Alex Hogan/STAT

Top of the morning to you, and a fine one it is. Cold winds and overcast skies will not deter us from celebrating another brand new day here on the Pharmalot campus, where

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Drug For Lung Cancer, A Novo Plant Fire, And More
The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.

Related Books & Audiobooks